Global Information
회사소개 | 문의 | 비교리스트

비침습적 산전 검사(NIPT) 시장 : 세계 산업 동향, 점유율, 규모, 성장, 기회, 예측(2020-2025년)

Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

리서치사 IMARC Services Private Limited
발행일 2020년 06월 상품 코드 945258
페이지 정보 영문 105 Pages
가격
US $ 2,299 ₩ 2,716,000 PDF (Single User License)
US $ 3,399 ₩ 4,016,000 PDF (5 User License)
US $ 4,499 ₩ 5,316,000 PDF (Corporate License)


비침습적 산전 검사(NIPT) 시장 : 세계 산업 동향, 점유율, 규모, 성장, 기회, 예측(2020-2025년) Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
발행일 : 2020년 06월 페이지 정보 : 영문 105 Pages

세계의 비침습적 산전 검사(NIPT) 시장은 현재 강력한 성장을 이루고 있습니다. 태아의 유전성 질환 유병률 증가는 시장 성장을 견인하는 중요한 요소의 하나입니다. 또한 생명과학 및 헬스케어 분야의 기술 진보도 시장을 지지하고 있습니다. 예를 들어 DNA 시퀀스 기술 개발, 재생의료, 분자 연구 진보는 초기 단계에서 심각한 질병에 유효한 큰 가능성을 가져왔습니다. 또한 산전 검사 채용률 증가, 건강에 대한 인식 확산 및 대중 사이에서 그러한 검사의 이점과 중요성에 관한 인식도 시장 성장을 견인하고 있습니다. 헬스케어 프로바이더는 출산 예정 부모와 같이 이분척추, 구개열, 겸상 적혈구 빈혈을 포함한 기타 유전성 질환을 진단하고, 태아 발육 초기 단계에서 그것들을 치료하는 대체 수단을 채용하고 있습니다. 또한 높은 임산부 연령(35세 이상)으로 출산하는 경향이 높아지고 있는 점도 시장 성장에 플러스 영향을 미치고 있습니다. 임산부 연령이 높아지면 고혈압, 출생률 저하, 유산 위험, 태아 염색체 이상 위험 증가 등 많은 합병증을 일으킬 가능성이 있습니다. IMARC Group은 2020-2025년간 시장이 약 12%의 CAGR을 기록할 것으로 예측하고 있습니다.

세계의 비침습적 산전 검사(NIPT) 시장에 대해 조사했으며, 시장 개요, 각 부문 및 지역별 시장 규모 예측, 주요 기업 개요, 경쟁 상황 분석 등 체계적인 정보를 제공합니다.

제1장 서문

제2장 범위와 조사 방법

제3장 주요 요약

제4장 서론

제5장 세계의 비침습적 산전 검사(NIPT) 시장

  • 시장 개요
  • 시장 실적

제6장 시장 분석 : 제품 종류별

  • 소모품
  • 장비

제7장 시장 분석 : 테스트 종류별

  • Materni
  • Harmony
  • Panaroma
  • Verifi
  • NIFTY
  • 기타

제8장 시장 분석 : 기술별

  • NGS
  • WGS
  • 기타

제9장 시장 분석 : 방법별

  • 초음파 검출
  • 생화학적 스크리닝 테스트
  • 모체 혈장 검사의 Cell-Free DNA
  • 모체 혈액 검사의 태아 세포
  • 기타 테스트

제10장 시장 분석 : 용도별

  • 삼염색체
  • 미세결실 증후군
  • 기타

제11장 시장 분석 : 최종사용자별

  • 병원
  • 임상 검사실
  • 기타

제12장 시장 분석 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동과 아프리카
    • 시장 분석 : 국가별

제13장 SWOT 분석

제14장 밸류체인 분석

제15장 Porter's Five Forces 분석

제16장 경쟁 상황

  • 시장 구조
  • 주요 기업
  • 주요 기업 개요
    • Agilent Technologies, Inc.
    • Berry Genetics, Inc.
    • BGI Genomics Co., Ltd.
    • Eurofins LifeCodexx GmbH
    • F. Hoffmann-La Roche AG
    • GE Medical Systems
    • Igenomix
    • Illumina, Inc.
    • Laboratory Corporation
    • Natera, Inc.
    • Perkinelmer, Inc.
    • Thermo Fisher Scientific Inc.
    • Yourgene Health
KSM 20.07.13

List of Figures

  • Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2019
  • Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2019
  • Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2019
  • Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2019
  • Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2019
  • Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2019
  • Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2019
  • Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: Global: Non-Invasive Prenatal Testing (Other Tests) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: Global: Non-Invasive Prenatal Testing (Other Tests) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
  • Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
  • Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million US$), 2020-2025
  • Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million US$), 2020-2025
  • Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology Type (in Million US$), 2020-2025
  • Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million US$), 2020-2025
  • Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup End-User (in Million US$), 2020-2025
  • Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 9: Global: Non-Invasive Prenatal Testing Market Structure
  • Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players

The global non-invasive prenatal testing market is currently witnessing strong growth. Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman's blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother's blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.

The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus. Looking forward, IMARC Group expects the market to register a CAGR of around 12% during 2020-2025.

Breakup by Product Type:

  • Consumables
  • Instruments

Breakup by Test Type:

  • Materni 21
  • Harmony
  • Panaroma
  • Verifi
  • NIFTY
  • Others

Breakup by Technology:

  • NGS
  • WGS
  • Others

Breakup by Test Type:

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-Free DNA in Maternal Plasma Tests
  • Fetal Cells in Maternal Blood Tests
  • Others

Breakup by Application:

  • Trisomy
  • Microdeletions Syndrome
  • Others

Breakup by End-User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Berry Genetics Inc., BGI Genomics Co. Ltd., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche AG, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., Perkinelmer Inc., Thermo Fisher Scientific Inc., Yourgene Health, etc.

Key Questions Answered in This Report:

  • How has the global non-invasive prenatal testing market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the method?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global non-invasive prenatal testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Non-Invasive Prenatal Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Materni 21
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Harmony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Panaroma
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Verifi
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 NIFTY
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 NGS
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 WGS
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Method

  • 9.1 Ultrasound Detection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Screening Tests
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Fetal Cells in Maternal Blood Tests
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Other Tests
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Trisomy
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Microdeletion Syndrome
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Diagnostic Laboratories
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies, Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Berry Genetics, Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 BGI Genomics Co., Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Eurofins LifeCodexx GmbH
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 F. Hoffmann-La Roche AG
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 GE Medical Systems
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Igenomix
      • 16.3.7.1 Company. Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Illumina, Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Laboratory Corporation
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Natera, Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Perkinelmer, Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Thermo Fisher Scientific Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Yourgene Health
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
Back to Top
전화 문의
F A Q